ResMed

OverviewSuggest Edit

ResMed is a company that specializes in digital health and cloud-connected medical devices. It operates in two segments, the Sleep and Respiratory Care segment and the Software as a Service (SaaS). The company develops, manufactures, and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. ResMed offers a number of products, including airflow generators, diagnostic products, mask systems, cloud-connected CPAP machines, cloud-connected ventilators, portable oxygen, headgear, and other accessories. Furthermore, the company provides a network of out-of-hospital healthcare management solutions designed to help providers deliver personalized care.
TypePublic
Founded1989
HQSan Diego, CA, US
Websiteresmed.com
Employee Ratings4
Overall CultureA+

Latest Updates

Employees (est.) (Jun 2021)7,970(+3%)
Job Openings528
Revenue (FY, 2021)$3.2 B(+9%)
Share Price (Jun 2022)$211.5(+2%)
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at ResMed

Michael Mick Farrell

Michael Mick Farrell

CEO
Rob Douglas

Rob Douglas

President and Chief Operating Officer
David Pendarvis

David Pendarvis

Chief Administrative Officer, Global General Counsel
Jim Hollingshead

Jim Hollingshead

President, Sleep Business
McHale Richie

McHale Richie

Chief Transformation Officer
Raj Sodhi

Raj Sodhi

President, SaaS Business
Show more

ResMed Office Locations

ResMed has offices in San Diego, Bella Vista, Kontich, São Paulo and in 18 other locations
San Diego, CA, US (HQ)
9001 Spectrum Center Blvd
Bella Vista, AU
1 Elizabeth Macarthur Dr
Kontich, BE
50 Grote Steenweg
São Paulo, BR
Roque Petroni Junior Avenue, 850 Bacaetava Tower
Chaoyang, CN
12th Floor, Building, 12 Taiyanggong Middle Rd, Chaoyang Qu
Espoo, FI
3 Hevosenkenkä
Show all (22)

ResMed Financials and Metrics

ResMed Revenue

Embed Graph
View revenue for all periods
ResMed's revenue was reported to be $3.2 b in FY, 2021 which is a 8.1% increase from the previous period.
USD

Revenue (Q1, 2022)

904.0m

Gross profit (Q1, 2022)

506.3m

Gross profit margin (Q1, 2022), %

56%

Net income (Q1, 2022)

203.6m

EBIT (Q1, 2022)

261.9m

Market capitalization (24-Jun-2022)

30.8b

Closing stock price (24-Jun-2022)

211.5

Cash (30-Sept-2021)

276.1m

EV

31.5b
ResMed's current market capitalization is $30.8 b.
Annual
USDFY, 2019FY, 2020FY, 2021

Revenue

2.6b3.0b3.2b

Revenue growth, %

13%8%

Cost of goods sold

1.1b1.2b1.4b

Gross profit

1.5b1.7b1.8b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Revenue

681.1m736.2m769.5m751.9m800.0m768.8m904.0m

Cost of goods sold

276.0m309.0m319.8m313.3m337.5m321.5m397.7m

Gross profit

405.1m427.1m449.7m438.7m462.5m447.3m506.3m

Gross profit Margin, %

59%58%58%58%58%58%56%
Annual
USDFY, 2019FY, 2020FY, 2021

Cash

147.1m463.2m295.3m

Accounts Receivable

528.5m474.6m614.3m

Inventories

349.6m416.9m457.0m

Current Assets

1.1b1.5b1.6b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Cash

172.2m204.1m352.9m421.4m255.9m230.6m276.1m

Accounts Receivable

493.8m528.0m554.9m464.9m509.4m525.0m575.6m

Inventories

357.0m377.8m358.8m478.0m474.8m484.1m506.6m

Current Assets

1.2b1.3b1.5b1.5b1.5b1.5b1.6b
Annual
USDFY, 2019FY, 2020FY, 2021

Net Income

404.6m621.7m474.5m

Depreciation and Amortization

150.8m154.9m156.8m

Inventories

(84.2m)(69.9m)(22.0m)

Accounts Payable

(27.3m)(23.4m)210.7m
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Net Income

120.1m280.7m443.8m178.4m357.9m279.4m203.6m

Depreciation and Amortization

38.0m77.1m116.3m39.5m80.0m120.0m39.1m

Inventories

(14.2m)(28.3m)(22.6m)(52.4m)(34.2m)(48.4m)(56.0m)

Accounts Payable

(30.1m)(88.9m)(57.3m)(61.3m)(99.3m)158.1m(293.3m)
USDFY, 2019

EV/EBIT

32.1 x

EV/CFO

40.6 x

Revenue/Employee

360.0k

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2 x

P/E Ratio

43.6
Show all financial metrics

ResMed Operating Metrics

FY, 2019FY, 2020FY, 2021

Patents (Foreign)

7051.45 k1.42 k

Patents (US)

259570598

Patents Pending

5.7 k6.2 k8.3 k

ResMed Acquisitions / Subsidiaries

Company NameDateDeal Size
Propeller HealthDecember 07, 2018
MatrixcareNovember 05, 2018$750 m

ResMed Revenue Breakdown

Embed Graph

ResMed revenue breakdown by business segment: 11.7% from Software as a Service, 37.9% from Masks and Other and 50.4% from Devices

ResMed revenue breakdown by geographic segment: 38.6% from Rest of the World and 61.4% from United States

ResMed Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

ResMed Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

ResMed Online and Social Media Presence

Embed Graph

ResMed Company Culture

  • Overall Culture

    A+

    81/100

  • CEO Rating

    A+

    90/100

  • Compensation

    A

    81/100

  • Diversity

    B

    74/100

Learn more on Comparably

ResMed News and Updates

ResMed buys German digital healthcare platform MEDIFOX DAN for $1 billion

Software and services investor Hg has sold German digital care platform MEDIFOX DAN to San Diego-based ResMed in a transaction valuing the business at an enterprise value of around $1 billion. The new...

ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions

SAN DIEGO and HILDESHEIM, Germany, June 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German leader in out-of-hospital software solutions for providers in major settings across the care continuum, from Hg, …

ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference

SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Tuesday, June 14, 2022, beginning at approximately 1:20 p.m. (Pacific Daylight T…

ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference

SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022, beginning at approximately 9:20 a.m. (Central Daylight Time) at the Lo…

ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference

SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, beginning at approximately 1:30 p.m. (Eastern Daylight Tim…

Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study

SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE) -- Sleep apnea sufferers can gain health benefits from PAP (positive airway pressure) treatment in as little as two hours per night, according to a study led by ResMed (NYSE: RMD, ASX: RMD) and presented at the American Thoracic Society’s annual Interna…
Show more

ResMed Frequently Asked Questions

  • When was ResMed founded?

    ResMed was founded in 1989.

  • Who are ResMed key executives?

    ResMed's key executives are Michael Mick Farrell, Rob Douglas and David Pendarvis.

  • How many employees does ResMed have?

    ResMed has 7,970 employees.

  • What is ResMed revenue?

    Latest ResMed annual revenue is $3.2 b.

  • What is ResMed revenue per employee?

    Latest ResMed revenue per employee is $401.1 k.

  • Who are ResMed competitors?

    Competitors of ResMed include Hillrom, DeVilbiss and Apex Medical.

  • Where is ResMed headquarters?

    ResMed headquarters is located at 9001 Spectrum Center Blvd, San Diego.

  • Where are ResMed offices?

    ResMed has offices in San Diego, Bella Vista, Kontich, São Paulo and in 18 other locations.

  • How many offices does ResMed have?

    ResMed has 22 offices.